KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Retained Earnings (2016 - 2025)

HCA Healthcare (HCA) has disclosed Retained Earnings for 16 consecutive years, with -$5.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 170.64% to -$5.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.7 billion, a 170.64% decrease, with the full-year FY2025 number at -$5.7 billion, down 170.64% from a year prior.
  • Retained Earnings was -$5.7 billion for Q4 2025 at HCA Healthcare, down from -$5.0 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $735.0 million in Q1 2021 to a low of -$5.7 billion in Q4 2025.
  • A 5-year average of -$1.7 billion and a median of -$888.5 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: surged 228.72% in 2021, then crashed 2518.18% in 2022.
  • HCA Healthcare's Retained Earnings stood at -$404.0 million in 2021, then dropped by 21.29% to -$490.0 million in 2022, then rose by 13.27% to -$425.0 million in 2023, then crashed by 397.65% to -$2.1 billion in 2024, then tumbled by 170.64% to -$5.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Retained Earnings are -$5.7 billion (Q4 2025), -$5.0 billion (Q3 2025), and -$4.1 billion (Q2 2025).